---
title: "BioStem Technologies prices USD 3 million at-the-market private placement under Nasdaq rules"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300569173.md"
description: "BioStem Technologies priced a USD 3 million at-the-market private placement of 735,296 common shares at USD 4.08 each. The deal includes Series A and B warrants for an additional potential raise of USD 5.6 million. Proceeds are for working capital and general corporate purposes, with closing expected Sept. 30, 2026. H.C. Wainwright served as the exclusive placement agent."
datetime: "2026-09-30T12:04:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300569173.md)
  - [en](https://longbridge.com/en/news/300569173.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300569173.md)
generator: "portal-rs"
---

# BioStem Technologies prices USD 3 million at-the-market private placement under Nasdaq rules

-   BioStem Technologies priced a USD 3 million at-the-market private placement of 735,296 common shares at USD 4.08 each. \* Deal includes Series A warrants for 735,296 shares plus Series B warrants for 735,296 shares, exercisable immediately at USD 3.83. \* Warrants could raise an additional USD 5.6 million if fully exercised for cash. \* Closing expected Sept. 30, 2026; proceeds earmarked for working capital and general corporate purposes. \* H.C. Wainwright is exclusive placement agent. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biostem Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609300800PRIMZONEFULLFEED9836770) on September 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [BSEM.US](https://longbridge.com/en/quote/BSEM.US.md)

## Related News & Research

- [BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants](https://longbridge.com/en/news/300618358.md)
- [BioStem secures USD 40 million equity facility via private placement with Roth affiliate](https://longbridge.com/en/news/299437694.md)
- [TTM Technologies Q3 net income jumps 60% to $84.8 million; Q3 net sales rise 60% to $1.2 billion](https://longbridge.com/en/news/302693400.md)
- [TTMI: Record Q3 results and strong backlog support a $6.5–6.75B FY2027 sales outlook](https://longbridge.com/en/news/302694237.md)
- [TTM Technologies (NASDAQ:TTMI) Releases Earnings Results](https://longbridge.com/en/news/302723916.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**